Clinical trial
Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With…
NCT00489671 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00489671 |
|---|---|
| Title | Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis |
| Official title | Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis: Value of the Detection of Urinary Cadmium |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Pancreatic Cancer, Precancerous Condition |
| Enrollment | 32 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Jun 21, 2007 |
| Last update posted | Jan 19, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: